Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Lulu Wei"'
Autor:
Yan Shi, Candy Lee, Peng Sang, Zaid Amso, David Huang, Weixia Zhong, Meng Gu, Lulu Wei, Vân T.B. Nguyen-Tran, Jingyao Zhang, Weijun Shen, Jianfeng Cai
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 13, Iss 4, Pp 1648-1659 (2023)
Peptides are increasingly important resources for biological and therapeutic development, however, their intrinsic susceptibility to proteolytic degradation represents a big hurdle. As a natural agonist for GLP-1R, glucagon-like peptide 1 (GLP-1) is
Externí odkaz:
https://doaj.org/article/91dc5f2999f64c208779cc3f9f338555
Autor:
Wenyuan Pu, Zhenzi Su, Junaid Wazir, Chen Zhao, Lulu Wei, Ranran Wang, Qiyi Chen, Saifang Zheng, Shaoyi Zhang, Hongwei Wang
Publikováno v:
Molecular Medicine, Vol 28, Iss 1, Pp 1-17 (2022)
Abstract Background Inflammatory bowel disease (IBD) is a common chronic remitting disease with no satisfactory treatment. The aim of this study was to investigate the protective effect of α7 nicotinic acetylcholine receptor (α7nAChR), and to deter
Externí odkaz:
https://doaj.org/article/00f0dbc7037549058614d1506694fa27
Autor:
Lulu Wei, Ranran Wang, Kai Lin, Xiaolu Jin, Li Li, Junaid Wazir, Wenyuan Pu, Panpan Lian, Renwei Lu, Shiyu Song, Quan Zhao, Jiabin Li, Hongwei Wang
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Cancer cachexia is a multifactorial syndrome defined by progressive loss of body weight with specific depletion of skeletal muscle and adipose tissue. Since there are no FDA-approved drugs that are available, nutritional intervention is recommended a
Externí odkaz:
https://doaj.org/article/9d82ba1eae48447d9cf4cd0671f522a5
Autor:
Mengmeng Zheng, Chunpu Li, Mi Zhou, Ru Jia, Fengyu She, Lulu Wei, Feng Cheng, Qi Li, Jianfeng Cai, Yan Wang
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 11, Iss 9, Pp 2645-2654 (2021)
Inhibition of human epidermal growth factor receptor 2 mediated cell signaling pathway is an important therapeutic strategy for HER2-positive cancers. Although monoclonal antibodies are currently used as marketed drugs, their large molecular weight,
Externí odkaz:
https://doaj.org/article/2f3cfecb2393444c98a962b9b02027c1
Autor:
Jianfeng Cai, Lulu Wei
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 11, Iss 9, Pp 2606-2608 (2021)
Externí odkaz:
https://doaj.org/article/5ecc68d255bd4801a119b5cc532a6465
Targeting HSP90 Inhibits Proliferation and Induces Apoptosis Through AKT1/ERK Pathway in Lung Cancer
Autor:
Mengyuan Niu, Bin Zhang, Li Li, Zhonglan Su, Wenyuan Pu, Chen Zhao, Lulu Wei, Panpan Lian, Renwei Lu, Ranran Wang, Junaid Wazir, Qian Gao, Shiyu Song, Hongwei Wang
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2022)
Lung cancer is one of the most common malignant cancers worldwide. Searching for specific cancer targets and developing efficient therapies with lower toxicity is urgently needed. HPS90 is a key chaperon protein that has multiple client proteins invo
Externí odkaz:
https://doaj.org/article/050fc34a7af7470987a6751a0de9cbb0
Autor:
Lulu Wei, Jianfeng Cai
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 11, Iss 9, Pp 2606-2608 (2021)
Acta Pharmaceutica Sinica. B
Acta Pharmaceutica Sinica. B